Share Price and Basic Stock Data
Last Updated: November 8, 2025, 4:40 am
| PEG Ratio | 0.00 |
|---|
Analyst Insight & Comprehensive Analysis
Business Overview and Revenue Trends
AGS Transact Technologies Ltd operates within the financial technologies sector, focusing on providing integrated payment solutions. The company’s revenue performance over the last few years has shown volatility. For the fiscal year ending March 2024, AGS reported sales of ₹1,471 Cr, down from ₹1,671 Cr in March 2023, indicating a decline of approximately 12%. In the trailing twelve months (TTM), sales stood at ₹1,250 Cr. Quarterly sales have also fluctuated; for instance, in the most recent quarter of September 2023, the sales figure was ₹377 Cr, down from ₹425 Cr in March 2023. The company’s operational challenges are evident, as it recorded a significant drop in sales towards the latter part of the year, culminating in a notable decrease to ₹210 Cr in December 2024. This declining trend raises concerns about the company’s market positioning amidst a competitive fintech landscape.
Profitability and Efficiency Metrics
Profitability for AGS Transact has been under pressure, with the company reporting a net profit of ₹-80 Cr for the fiscal year ending March 2024, a stark contrast to the ₹37 Cr profit recorded in March 2023. The operating profit margin (OPM) has also seen a dramatic decline, registering at just 13% in March 2024 compared to 24% in the previous year. This drop in margins reflects rising operational costs, with total expenses standing at ₹1,273 Cr for March 2024, unchanged from the previous year. The interest coverage ratio (ICR) is also concerning, at 1.59x, suggesting limited ability to cover interest obligations amid rising debts. Furthermore, the cash conversion cycle (CCC) has worsened to -578 days, indicating significant inefficiencies in managing working capital, which could pose risks to liquidity and operational sustainability.
Balance Sheet Strength and Financial Ratios
AGS Transact’s balance sheet presents a mixed picture. As of March 2024, total borrowings stood at ₹1,120 Cr, which is a decrease from ₹1,231 Cr in March 2023. However, this drop is accompanied by a decline in reserves, which were reported at ₹341 Cr in March 2024, down from ₹415 Cr in March 2023. The debt-to-equity ratio is concerning at 1.78x, indicating high leverage relative to equity. Furthermore, the return on capital employed (ROCE) is low at 2.05%, suggesting that the company is not effectively utilizing its capital to generate profits. The price-to-book value ratio (P/BV) stood at 1.78x, which is relatively high compared to typical sector norms, indicating that investors may be pricing in future growth that has yet to materialize. This financial strain could limit growth opportunities unless operational efficiencies are improved.
Shareholding Pattern and Investor Confidence
The shareholding pattern of AGS Transact Technologies reflects changing investor confidence. Promoters held 26.47% of the company as of September 2024, a significant decline from 65.52% in December 2022. This reduction in promoter stake could signal potential concerns about the company’s future. Institutional investors also show limited interest, with foreign institutional investors (FIIs) holding only 0.12% and domestic institutional investors (DIIs) at 7.14%. The public shareholding has drastically increased from 21.57% in September 2022 to 66.00% in June 2025, indicating a shift towards retail investor dominance. The number of shareholders has also increased to 1,05,013, suggesting a growing interest among retail investors despite the company’s recent performance challenges, which may reflect a speculative sentiment rather than fundamental confidence.
Outlook, Risks, and Final Insight
Looking ahead, AGS Transact Technologies faces several risks that could impact its operational viability and market positioning. The declining revenue and profitability trends, coupled with a high debt burden, pose significant challenges. The company’s ability to reverse these trends will depend on improving operational efficiencies and managing costs effectively. Furthermore, the declining promoter stake may raise concerns among investors regarding future governance and strategic direction. However, there are opportunities for growth in the fintech sector, especially if AGS can leverage its technological capabilities to innovate and enhance its service offerings. The ability to attract institutional investors and stabilize its financial metrics will be crucial for restoring investor confidence and achieving long-term sustainability. In a scenario where operational improvements are realized, AGS could see a recovery in both revenue and profitability, but failure to address current inefficiencies may lead to further declines.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of AGS Transact Technologies Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| AGS Transact Technologies Ltd | 52.7 Cr. | 4.10 | 93.8/3.78 | 41.8 | 0.00 % | 1.26 % | 16.3 % | 10.0 | |
| Infibeam Avenues Ltd | 5,922 Cr. | 18.3 | 26.4/12.6 | 27.6 | 10.7 | 0.00 % | 8.65 % | 6.47 % | 1.00 |
| DigiSpice Technologies Ltd | 591 Cr. | 25.2 | 35.5/17.1 | 143 | 9.10 | 0.00 % | 5.47 % | 2.71 % | 3.00 |
| Industry Average | 3,256.50 Cr | 15.87 | 85.30 | 20.53 | 0.00% | 5.13% | 8.49% | 4.67 |
Quarterly Result
| Metric | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 485 | 399 | 418 | 414 | 415 | 425 | 371 | 377 | 374 | 349 | 340 | 352 | 210 |
| Expenses | 365 | 324 | 305 | 305 | 315 | 351 | 288 | 369 | 316 | 300 | 246 | 263 | 384 |
| Operating Profit | 119 | 75 | 113 | 109 | 101 | 73 | 83 | 7 | 58 | 49 | 93 | 88 | -174 |
| OPM % | 25% | 19% | 27% | 26% | 24% | 17% | 22% | 2% | 15% | 14% | 28% | 25% | -83% |
| Other Income | 8 | 6 | 10 | 7 | 9 | 10 | 8 | 12 | 10 | 8 | 12 | 16 | 4 |
| Interest | 61 | 72 | 35 | 34 | 35 | 39 | 37 | 37 | 38 | 37 | 36 | 36 | 38 |
| Depreciation | 65 | 65 | 59 | 58 | 56 | 57 | 54 | 54 | 53 | 53 | 49 | 48 | 44 |
| Profit before tax | 2 | -56 | 28 | 23 | 19 | -13 | 1 | -71 | -23 | -32 | 20 | 21 | -252 |
| Tax % | 634% | -14% | 32% | 11% | 35% | 20% | 36% | -14% | -32% | -86% | 32% | 27% | -23% |
| Net Profit | -9 | -48 | 19 | 21 | 12 | -15 | 1 | -61 | -15 | -4 | 14 | 15 | -194 |
| EPS in Rs | -0.78 | -3.98 | 1.58 | 1.70 | 1.02 | -1.27 | 0.05 | -5.02 | -1.27 | -0.37 | 1.14 | 1.24 | -15.17 |
Last Updated: February 28, 2025, 3:48 pm
Below is a detailed analysis of the quarterly data for AGS Transact Technologies Ltd based on the most recent figures (Dec 2024) and their trends compared to the previous period:
- For Sales, as of Dec 2024, the value is 210.00 Cr.. The value appears to be declining and may need further review. It has decreased from 352.00 Cr. (Sep 2024) to 210.00 Cr., marking a decrease of 142.00 Cr..
- For Expenses, as of Dec 2024, the value is 384.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 263.00 Cr. (Sep 2024) to 384.00 Cr., marking an increase of 121.00 Cr..
- For Operating Profit, as of Dec 2024, the value is -174.00 Cr.. The value appears to be declining and may need further review. It has decreased from 88.00 Cr. (Sep 2024) to -174.00 Cr., marking a decrease of 262.00 Cr..
- For OPM %, as of Dec 2024, the value is -83.00%. The value appears to be declining and may need further review. It has decreased from 25.00% (Sep 2024) to -83.00%, marking a decrease of 108.00%.
- For Other Income, as of Dec 2024, the value is 4.00 Cr.. The value appears to be declining and may need further review. It has decreased from 16.00 Cr. (Sep 2024) to 4.00 Cr., marking a decrease of 12.00 Cr..
- For Interest, as of Dec 2024, the value is 38.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 36.00 Cr. (Sep 2024) to 38.00 Cr., marking an increase of 2.00 Cr..
- For Depreciation, as of Dec 2024, the value is 44.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 48.00 Cr. (Sep 2024) to 44.00 Cr., marking a decrease of 4.00 Cr..
- For Profit before tax, as of Dec 2024, the value is -252.00 Cr.. The value appears to be declining and may need further review. It has decreased from 21.00 Cr. (Sep 2024) to -252.00 Cr., marking a decrease of 273.00 Cr..
- For Tax %, as of Dec 2024, the value is -23.00%. The value appears to be improving (decreasing) as expected. It has decreased from 27.00% (Sep 2024) to -23.00%, marking a decrease of 50.00%.
- For Net Profit, as of Dec 2024, the value is -194.00 Cr.. The value appears to be declining and may need further review. It has decreased from 15.00 Cr. (Sep 2024) to -194.00 Cr., marking a decrease of 209.00 Cr..
- For EPS in Rs, as of Dec 2024, the value is -15.17. The value appears to be declining and may need further review. It has decreased from 1.24 (Sep 2024) to -15.17, marking a decrease of 16.41.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: May 15, 2025, 4:36 am
| Metric | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | TTM |
|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,308 | 1,473 | 1,806 | 1,800 | 1,759 | 1,772 | 1,671 | 1,471 | 1,250 |
| Expenses | 1,154 | 1,262 | 1,376 | 1,336 | 1,321 | 1,361 | 1,273 | 1,273 | 1,193 |
| Operating Profit | 154 | 211 | 429 | 465 | 437 | 411 | 398 | 197 | 57 |
| OPM % | 12% | 14% | 24% | 26% | 25% | 23% | 24% | 13% | 5% |
| Other Income | 15 | 9 | 13 | 30 | 38 | 24 | 34 | 38 | 40 |
| Interest | 78 | 83 | 137 | 130 | 133 | 250 | 144 | 148 | 147 |
| Depreciation | 100 | 113 | 227 | 245 | 260 | 252 | 231 | 213 | 193 |
| Profit before tax | -10 | 24 | 79 | 120 | 82 | -67 | 58 | -125 | -243 |
| Tax % | 109% | 73% | 16% | 31% | 34% | 24% | 36% | -36% | |
| Net Profit | -22 | 6 | 66 | 83 | 55 | -82 | 37 | -80 | -170 |
| EPS in Rs | -1.79 | 0.52 | 5.50 | 6.89 | 4.55 | -6.79 | 3.04 | -6.60 | -13.16 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 22% | 0% | 0% | 0% |
YoY Net Profit Growth
| Year | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 |
|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 127.27% | 1000.00% | 25.76% | -33.73% | -249.09% | 145.12% | -316.22% |
| Change in YoY Net Profit Growth (%) | 0.00% | 872.73% | -974.24% | -59.49% | -215.36% | 394.21% | -461.34% |
AGS Transact Technologies Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 7 years from 2017-2018 to 2023-2024.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | -4% |
| 3 Years: | -6% |
| TTM: | -19% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | -86% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | -60% |
| 1 Year: | -95% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | 1% |
| 3 Years: | -8% |
| Last Year: | -16% |
Last Updated: September 5, 2025, 2:11 pm
No data available for the Balance Sheet data table.
Cash Flow - No data available for this post.
Free Cash Flow
| Month | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -503.00 | -492.00 | 428.00 | 464.00 | 436.00 | 410.00 | 397.00 | 196.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
|---|---|---|---|---|---|---|---|---|
| Debtor Days | 82 | 91 | 90 | 93 | 102 | 188 | 197 | 181 |
| Inventory Days | 190 | 143 | 95 | 85 | 100 | 104 | 152 | 276 |
| Days Payable | 224 | 209 | 251 | 344 | 398 | 817 | 752 | 1,035 |
| Cash Conversion Cycle | 48 | 25 | -66 | -166 | -196 | -525 | -403 | -578 |
| Working Capital Days | 73 | 73 | -35 | -49 | -46 | -4 | 37 | -5 |
| ROCE % | 10% | 17% | 16% | 11% | 10% | 12% | 1% |
Mutual Fund Holdings
| Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
|---|---|---|---|---|---|---|
| HDFC Balanced Advantage Fund - Regular Plan | 4,587,241 | 0.07 | 53.17 | 4,587,241 | 2025-04-22 17:25:14 | 0% |
Key Financial Ratios
| Month | Mar 24 | Mar 23 | Mar 22 | Mar 21 | Mar 20 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | -6.64 | 3.07 | -6.93 | 4.62 | 7.00 |
| Diluted EPS (Rs.) | -6.64 | 3.01 | -6.93 | 4.55 | 6.90 |
| Cash EPS (Rs.) | 11.00 | 22.21 | 14.16 | 26.65 | 27.71 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 38.15 | 44.41 | 40.09 | 47.11 | 42.08 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 38.15 | 44.41 | 40.09 | 47.11 | 42.08 |
| Revenue From Operations / Share (Rs.) | 121.51 | 138.71 | 147.44 | 148.33 | 151.83 |
| PBDIT / Share (Rs.) | 19.47 | 35.84 | 36.31 | 40.20 | 41.78 |
| PBIT / Share (Rs.) | 1.85 | 16.70 | 15.35 | 18.31 | 21.15 |
| PBT / Share (Rs.) | -10.36 | 4.77 | -5.47 | 7.09 | 10.15 |
| Net Profit / Share (Rs.) | -6.62 | 3.07 | -6.80 | 4.76 | 7.07 |
| NP After MI And SOA / Share (Rs.) | -6.62 | 3.07 | -6.86 | 4.62 | 7.00 |
| PBDIT Margin (%) | 16.01 | 25.84 | 24.62 | 27.10 | 27.51 |
| PBIT Margin (%) | 1.52 | 12.04 | 10.40 | 12.34 | 13.92 |
| PBT Margin (%) | -8.52 | 3.44 | -3.71 | 4.77 | 6.68 |
| Net Profit Margin (%) | -5.44 | 2.21 | -4.60 | 3.20 | 4.65 |
| NP After MI And SOA Margin (%) | -5.44 | 2.21 | -4.65 | 3.11 | 4.61 |
| Return on Networth / Equity (%) | -17.34 | 6.90 | -17.11 | 9.80 | 16.63 |
| Return on Capital Employeed (%) | 2.05 | 15.13 | 15.01 | 12.62 | 20.61 |
| Return On Assets (%) | -3.82 | 1.61 | -3.50 | 1.88 | 3.70 |
| Long Term Debt / Equity (X) | 0.91 | 1.03 | 0.95 | 1.55 | 0.69 |
| Total Debt / Equity (X) | 1.78 | 1.64 | 1.48 | 2.21 | 1.36 |
| Asset Turnover Ratio (%) | 0.67 | 0.72 | 0.67 | 0.68 | 0.70 |
| Current Ratio (X) | 1.10 | 1.27 | 1.05 | 1.40 | 0.83 |
| Quick Ratio (X) | 1.01 | 1.20 | 0.99 | 1.34 | 0.77 |
| Inventory Turnover Ratio (X) | 1.31 | 2.33 | 2.94 | 3.14 | 3.02 |
| Dividend Payout Ratio (NP) (%) | 0.00 | 0.00 | -14.59 | 0.00 | 14.50 |
| Dividend Payout Ratio (CP) (%) | 0.00 | 0.00 | 7.10 | 0.00 | 3.67 |
| Earning Retention Ratio (%) | 0.00 | 0.00 | 114.59 | 0.00 | 85.50 |
| Cash Earning Retention Ratio (%) | 0.00 | 0.00 | 92.90 | 0.00 | 96.33 |
| Interest Coverage Ratio (X) | 1.59 | 3.01 | 1.74 | 3.58 | 3.80 |
| Interest Coverage Ratio (Post Tax) (X) | 0.45 | 1.26 | 0.67 | 1.42 | 1.64 |
| Enterprise Value (Cr.) | 1523.30 | 1343.55 | 1833.06 | 0.00 | 0.00 |
| EV / Net Operating Revenue (X) | 1.04 | 0.80 | 1.03 | 0.00 | 0.00 |
| EV / EBITDA (X) | 6.47 | 3.11 | 4.20 | 0.00 | 0.00 |
| MarketCap / Net Operating Revenue (X) | 0.55 | 0.33 | 0.67 | 0.00 | 0.00 |
| Retention Ratios (%) | 0.00 | 0.00 | 114.59 | 0.00 | 85.49 |
| Price / BV (X) | 1.78 | 1.04 | 2.49 | 0.00 | 0.00 |
| Price / Net Operating Revenue (X) | 0.55 | 0.33 | 0.67 | 0.00 | 0.00 |
| EarningsYield | -0.09 | 0.06 | -0.06 | 0.00 | 0.00 |
After reviewing the key financial ratios for AGS Transact Technologies Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 24, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 24, the value is -6.64. This value is below the healthy minimum of 5. It has decreased from 3.07 (Mar 23) to -6.64, marking a decrease of 9.71.
- For Diluted EPS (Rs.), as of Mar 24, the value is -6.64. This value is below the healthy minimum of 5. It has decreased from 3.01 (Mar 23) to -6.64, marking a decrease of 9.65.
- For Cash EPS (Rs.), as of Mar 24, the value is 11.00. This value is within the healthy range. It has decreased from 22.21 (Mar 23) to 11.00, marking a decrease of 11.21.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 38.15. It has decreased from 44.41 (Mar 23) to 38.15, marking a decrease of 6.26.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 38.15. It has decreased from 44.41 (Mar 23) to 38.15, marking a decrease of 6.26.
- For Revenue From Operations / Share (Rs.), as of Mar 24, the value is 121.51. It has decreased from 138.71 (Mar 23) to 121.51, marking a decrease of 17.20.
- For PBDIT / Share (Rs.), as of Mar 24, the value is 19.47. This value is within the healthy range. It has decreased from 35.84 (Mar 23) to 19.47, marking a decrease of 16.37.
- For PBIT / Share (Rs.), as of Mar 24, the value is 1.85. This value is within the healthy range. It has decreased from 16.70 (Mar 23) to 1.85, marking a decrease of 14.85.
- For PBT / Share (Rs.), as of Mar 24, the value is -10.36. This value is below the healthy minimum of 0. It has decreased from 4.77 (Mar 23) to -10.36, marking a decrease of 15.13.
- For Net Profit / Share (Rs.), as of Mar 24, the value is -6.62. This value is below the healthy minimum of 2. It has decreased from 3.07 (Mar 23) to -6.62, marking a decrease of 9.69.
- For NP After MI And SOA / Share (Rs.), as of Mar 24, the value is -6.62. This value is below the healthy minimum of 2. It has decreased from 3.07 (Mar 23) to -6.62, marking a decrease of 9.69.
- For PBDIT Margin (%), as of Mar 24, the value is 16.01. This value is within the healthy range. It has decreased from 25.84 (Mar 23) to 16.01, marking a decrease of 9.83.
- For PBIT Margin (%), as of Mar 24, the value is 1.52. This value is below the healthy minimum of 10. It has decreased from 12.04 (Mar 23) to 1.52, marking a decrease of 10.52.
- For PBT Margin (%), as of Mar 24, the value is -8.52. This value is below the healthy minimum of 10. It has decreased from 3.44 (Mar 23) to -8.52, marking a decrease of 11.96.
- For Net Profit Margin (%), as of Mar 24, the value is -5.44. This value is below the healthy minimum of 5. It has decreased from 2.21 (Mar 23) to -5.44, marking a decrease of 7.65.
- For NP After MI And SOA Margin (%), as of Mar 24, the value is -5.44. This value is below the healthy minimum of 8. It has decreased from 2.21 (Mar 23) to -5.44, marking a decrease of 7.65.
- For Return on Networth / Equity (%), as of Mar 24, the value is -17.34. This value is below the healthy minimum of 15. It has decreased from 6.90 (Mar 23) to -17.34, marking a decrease of 24.24.
- For Return on Capital Employeed (%), as of Mar 24, the value is 2.05. This value is below the healthy minimum of 10. It has decreased from 15.13 (Mar 23) to 2.05, marking a decrease of 13.08.
- For Return On Assets (%), as of Mar 24, the value is -3.82. This value is below the healthy minimum of 5. It has decreased from 1.61 (Mar 23) to -3.82, marking a decrease of 5.43.
- For Long Term Debt / Equity (X), as of Mar 24, the value is 0.91. This value is within the healthy range. It has decreased from 1.03 (Mar 23) to 0.91, marking a decrease of 0.12.
- For Total Debt / Equity (X), as of Mar 24, the value is 1.78. This value exceeds the healthy maximum of 1. It has increased from 1.64 (Mar 23) to 1.78, marking an increase of 0.14.
- For Asset Turnover Ratio (%), as of Mar 24, the value is 0.67. It has decreased from 0.72 (Mar 23) to 0.67, marking a decrease of 0.05.
- For Current Ratio (X), as of Mar 24, the value is 1.10. This value is below the healthy minimum of 1.5. It has decreased from 1.27 (Mar 23) to 1.10, marking a decrease of 0.17.
- For Quick Ratio (X), as of Mar 24, the value is 1.01. This value is within the healthy range. It has decreased from 1.20 (Mar 23) to 1.01, marking a decrease of 0.19.
- For Inventory Turnover Ratio (X), as of Mar 24, the value is 1.31. This value is below the healthy minimum of 4. It has decreased from 2.33 (Mar 23) to 1.31, marking a decrease of 1.02.
- For Dividend Payout Ratio (NP) (%), as of Mar 24, the value is 0.00. This value is below the healthy minimum of 20. There is no change compared to the previous period (Mar 23) which recorded 0.00.
- For Dividend Payout Ratio (CP) (%), as of Mar 24, the value is 0.00. This value is below the healthy minimum of 20. There is no change compared to the previous period (Mar 23) which recorded 0.00.
- For Earning Retention Ratio (%), as of Mar 24, the value is 0.00. This value is below the healthy minimum of 40. There is no change compared to the previous period (Mar 23) which recorded 0.00.
- For Cash Earning Retention Ratio (%), as of Mar 24, the value is 0.00. This value is below the healthy minimum of 40. There is no change compared to the previous period (Mar 23) which recorded 0.00.
- For Interest Coverage Ratio (X), as of Mar 24, the value is 1.59. This value is below the healthy minimum of 3. It has decreased from 3.01 (Mar 23) to 1.59, marking a decrease of 1.42.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 24, the value is 0.45. This value is below the healthy minimum of 3. It has decreased from 1.26 (Mar 23) to 0.45, marking a decrease of 0.81.
- For Enterprise Value (Cr.), as of Mar 24, the value is 1,523.30. It has increased from 1,343.55 (Mar 23) to 1,523.30, marking an increase of 179.75.
- For EV / Net Operating Revenue (X), as of Mar 24, the value is 1.04. This value is within the healthy range. It has increased from 0.80 (Mar 23) to 1.04, marking an increase of 0.24.
- For EV / EBITDA (X), as of Mar 24, the value is 6.47. This value is within the healthy range. It has increased from 3.11 (Mar 23) to 6.47, marking an increase of 3.36.
- For MarketCap / Net Operating Revenue (X), as of Mar 24, the value is 0.55. This value is below the healthy minimum of 1. It has increased from 0.33 (Mar 23) to 0.55, marking an increase of 0.22.
- For Retention Ratios (%), as of Mar 24, the value is 0.00. This value is below the healthy minimum of 30. There is no change compared to the previous period (Mar 23) which recorded 0.00.
- For Price / BV (X), as of Mar 24, the value is 1.78. This value is within the healthy range. It has increased from 1.04 (Mar 23) to 1.78, marking an increase of 0.74.
- For Price / Net Operating Revenue (X), as of Mar 24, the value is 0.55. This value is below the healthy minimum of 1. It has increased from 0.33 (Mar 23) to 0.55, marking an increase of 0.22.
- For EarningsYield, as of Mar 24, the value is -0.09. This value is below the healthy minimum of 5. It has decreased from 0.06 (Mar 23) to -0.09, marking a decrease of 0.15.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
Unable to fetch valid data for stock valuation.Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in AGS Transact Technologies Ltd:
- Net Profit Margin: -5.44%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 2.05% (Industry Average ROCE: 5.13%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: -17.34% (Industry Average ROE: 8.49%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 0.45
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 1.01
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 0 (Industry average Stock P/E: 85.3)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 1.78
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: -5.44%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Financial Technologies (Fintech) | 601-602, Trade World, B-Wing, Mumbai Maharashtra 400013 | companysecretary@agsindia.com. http://www.agsindia.com |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Ravi Badrinarain Goyal | Chairman & Managing Director |
| Mr. P Stanley Johnson | Executive Director |
| Mr. Vinayak R Goyal | Executive Director |
| Mr. Subrata Kumar Mitra | Ind. Non-Executive Director |
| Mr. Sudip Bandyopadhyay | Non Exe.Non Ind.Director |
| Mrs. Jhuma Guha | Ind. Non-Executive Director |
| Mr. Sivanandhan Dhanushkodi | Ind. Non-Executive Director |
| Ms. Preeti Malhotra | Ind. Non-Executive Director |